| Autor: |
Mariano ME; Department of Clinical Science, Unit of Pulmonary Function, University of Parma, Italy., Elia D, Scarascia A, Tzani P, Giucastro G, Olivieri D, Marangio E |
| Jazyk: |
angličtina |
| Zdroj: |
Acta bio-medica : Atenei Parmensis [Acta Biomed] 2009 Apr; Vol. 80 (1), pp. 42-6. |
| Abstrakt: |
The World Health Organization states that only a reduction in tobacco use would lower the number of deaths from cancer. It is possible to decrease the number of deaths by means of prevention and/or smoking cessation. Smoking cessation therapy includes both psychological support and pharmacological treatment: Nicotine Replacement Therapy (NRT), Bupropion Sustained-Release, and Varenicline. The aim of the Smoking Cessation Center of Parma is to provide instruments, methodologies and individual therapies for achieving abstinence or a decrease in tobacco use. The program of the Smoking Cessation Center consists in eight meetings. During the first meeting the smoker undergoes a medical check up, and smoking history, exhaled single breath CO and dependence of nicotine are recorded and a personal therapy is planned. During each follow-up visit (after 15 days and then at 1,2,3,6,9 and 12-month intervals) the compliance of the patient to the treatment and abstinence symptoms are assessed. Since 2000, we achieved tobacco abstinence in 28% of patients. Combined treatment (Bupropion/NRT) provided a higher percentage of success (39.9%). |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
